These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30360997)

  • 1. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "Prospective Data Registration and Clinical Trials for Particle Therapy" by Langendijk et al.
    Laprie A; Bernier V; Carrie C;
    Radiother Oncol; 2019 Jan; 130():193. PubMed ID: 30360997
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, Volume 165).
    Tuscano C; Al Sayyad S; Sceni G
    Radiother Oncol; 2022 Jul; 172():149-150. PubMed ID: 35413390
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, volume 165).
    Berger T; Noble DJ; Shelley LEA; Hopkins KI; McLaren DB; Burnet NG; Nailon WH
    Radiother Oncol; 2022 Jul; 172():151-152. PubMed ID: 35398383
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the editor of radiotherapy and oncology regarding of the paper "Radiotherapy enhances uptake and efficacy of
    Chen J; Liu G
    Radiother Oncol; 2021 Aug; 161():260. PubMed ID: 34119588
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.
    Beenakker JM; Rasch CRN
    Radiother Oncol; 2022 Nov; 176():251. PubMed ID: 35988772
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".
    Via R; Fattori G; Pica A; Paganelli C; Lomax A; Schalenbourg A; Weber DC; Baroni G; Hrbacek J
    Radiother Oncol; 2022 Nov; 176():252. PubMed ID: 35988774
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the editor regarding Mackillop et al., IJROBP 32:531-539; 1995.
    Rose CM
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):239-40. PubMed ID: 7642428
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor of radiotherapy and oncology regarding the article esposito et al: Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods.
    Kos S
    Radiother Oncol; 2020 Dec; 153():319. PubMed ID: 32653600
    [No Abstract]   [Full Text] [Related]  

  • 9. Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al.
    García-Foncillas J; Arnold D; Avouac B; Lassen U; Laurent-Puig P; Taieb J; Helland Å; Stenzinger A
    Ann Oncol; 2024 Jul; 35(7):677-678. PubMed ID: 38723866
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Runqiang Yuan and Hongxing Huang's Letter to the Editor re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214-20.
    Sivaraman A; Barret E
    Eur Urol; 2017 May; 71(5):e148-e149. PubMed ID: 28161029
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to the letter to the editor 'Integrating communication as a core skill in the global curriculum for medical oncology' by Horlait et al.
    Dittrich C; Stiefel F; Kiss A; Dizon DS
    Ann Oncol; 2017 Apr; 28(4):905-906. PubMed ID: 28049138
    [No Abstract]   [Full Text] [Related]  

  • 12. The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study.
    Cortellini A; Porzio G; Masel EK; Berghoff AS; Knotzer B; Parisi A; Pavese F; Ficorella C; Verna L
    Palliat Support Care; 2019 Feb; 17(1):82-86. PubMed ID: 29792235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al.
    Di Maio M; Marandino L; Perrone F
    Ann Oncol; 2019 Apr; 30(4):658-659. PubMed ID: 30698648
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a high standard of surgical oncology throughout Europe.
    O'Higgins N
    Eur J Cancer; 1995; 31A Suppl 6():S22-4. PubMed ID: 8534527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the editor regarding the manuscript entitled: "Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges" by Carolyn Johnston et al. (Gyneco Oncol Rep 2017; 20: 9-14).
    Srur-Rivero N; Fuster-Alfaro F; Araya-Vargas M; Araya-Fallas AL
    Gynecol Oncol Rep; 2018 May; 24():14. PubMed ID: 29552628
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective data registration and clinical trials for particle therapy in Europe.
    Langendijk JA; Orecchia R; Haustermans K; Zips D; Balosso J; Lacombe D; Lievens Y; Weber DC; Grau C; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):9-13. PubMed ID: 30056852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter in reply to Letter to the Editor concerning our paper entitled: Atrophy of anterior digastric muscle detected during ultrasound of the neck - a prospective clinical study.
    Gibson D; Dwivedi RC; Bowles C; Brennan PA
    Br J Oral Maxillofac Surg; 2016 Nov; 54(9):1056. PubMed ID: 26965010
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply letter to: pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participant - reply to Füssenich et al.: a new, simple and objective prognostic score for phase I cancer patients.
    van Herpen CM; Teerenstra S; Desar IM; van der Graaf WT
    Eur J Cancer; 2012 Mar; 48(4):597-8. PubMed ID: 22338604
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality assurance and quality control for radiotherapy/medical oncology in Europe: guideline development and implementation.
    Valentini V; Glimelius B; Frascino V
    Eur J Surg Oncol; 2013 Sep; 39(9):938-44. PubMed ID: 23830983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.